diaPatch™

About Curiva

Curiva is an early-stage diagnostics company pioneering a novel, non-invasive wearable patch (diaPatch™) designed to triage patients after an abnormal Pap smear. The patch uses microneedles to sample interstitial fluid from the lower abdomen and a molecular assay to detect tumor-associated biomarkers, targeting results within 30 minutes during the same clinical visit. Founded in 2018 and headquartered in Goshen, Indiana, with a presence in Chicago and San Diego, the company is pre-revenue and in the development stage, currently fundraising and planning regulatory pathways. Its initial focus is cervical cancer, with future potential in other gynecologic cancers.

Therapeutic Areas